 | • レポートコード：C-GIR20G2496 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「老化防止療法の世界市場2019年」は、グローバルにおける老化防止療法市場を展望するレポートです。老化防止療法のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・老化防止療法の市場概観 ・老化防止療法の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・老化防止療法の企業別販売動向、市場シェア、市場集中度、競争動向 ・老化防止療法の世界市場規模 ・老化防止療法の北米市場分析（アメリカ、カナダ、メキシコ等） ・老化防止療法のアメリカ市場規模推移 ・老化防止療法のカナダ市場規模推移 ・老化防止療法のメキシコ市場規模推移 ・老化防止療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・老化防止療法のドイツ市場規模推移 ・老化防止療法のイギリス市場規模推移 ・老化防止療法のロシア市場規模推移 ・老化防止療法のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・老化防止療法の日本市場規模推移 ・老化防止療法の中国市場規模推移 ・老化防止療法の韓国市場規模推移 ・老化防止療法のインド市場規模推移 ・老化防止療法の東南アジア市場規模推移 ・老化防止療法の南米市場分析（ブラジル、アルゼンチン等） ・老化防止療法の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・老化防止療法の種類別分析/販売量、売上、市場シェア（遺伝子治療、免疫療法、その他） ・老化防止療法の用途別分析/市場規模（心血管疾患、神経変性疾患、眼科疾患、その他） ・老化防止療法の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・老化防止療法の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Anti-Senescence Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Anti-Senescence Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Anti-Senescence Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Anti-Senescence Therapy market by product type and applications/end industries.
Market Segment by Companies, this report covers
Unity Biotechnology
OisinBiotechnologies
AgeX Therapeutics，Inc
Siwa Therapeutics
Cleara Biotech
Calico LLC
Sierra Sciences
Human Longevity, Inc. (HLI)
Numeric Biotech
Recursion Pharmaceuticals
Proteostasis Therapeutics
Senolytic Therapeutics
Allergan
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Gene Therapy
Immunotherapy
Others
Market Segment by Applications, can be divided into
Cardiovascular Diseases
Neural Degenerative Diseases
Ophthalmology Disorders
Others
Table of Contents
1 Anti-Senescence Therapy Market Overview
1.1 Product Overview and Scope of Anti-Senescence Therapy
1.2 Classification of Anti-Senescence Therapy by Types
1.2.1 Global Anti-Senescence Therapy Revenue Comparison by Types (2019-2024)
1.2.2 Global Anti-Senescence Therapy Revenue Market Share by Types in 2018
1.2.3 Gene Therapy
1.2.4 Immunotherapy
1.2.5 Others
1.3 Global Anti-Senescence Therapy Market by Application
1.3.1 Global Anti-Senescence Therapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Cardiovascular Diseases
1.3.3 Neural Degenerative Diseases
1.3.4 Ophthalmology Disorders
1.3.5 Others
1.4 Global Anti-Senescence Therapy Market by Regions
1.4.1 Global Anti-Senescence Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Anti-Senescence Therapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Anti-Senescence Therapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anti-Senescence Therapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Anti-Senescence Therapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anti-Senescence Therapy Status and Prospect (2014-2024)
1.5 Global Market Size of Anti-Senescence Therapy (2014-2024)
2 Company Profiles
2.1 Unity Biotechnology
2.1.1 Business Overview
2.1.2 Anti-Senescence Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Unity Biotechnology Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 OisinBiotechnologies
2.2.1 Business Overview
2.2.2 Anti-Senescence Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 OisinBiotechnologies Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 AgeX Therapeutics，Inc
2.3.1 Business Overview
2.3.2 Anti-Senescence Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AgeX Therapeutics，Inc Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Siwa Therapeutics
2.4.1 Business Overview
2.4.2 Anti-Senescence Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Siwa Therapeutics Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 Cleara Biotech
2.5.1 Business Overview
2.5.2 Anti-Senescence Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Cleara Biotech Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 Calico LLC
2.6.1 Business Overview
2.6.2 Anti-Senescence Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Calico LLC Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sierra Sciences
2.7.1 Business Overview
2.7.2 Anti-Senescence Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sierra Sciences Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.8 Human Longevity, Inc. (HLI)
2.8.1 Business Overview
2.8.2 Anti-Senescence Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Human Longevity, Inc. (HLI) Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.9 Numeric Biotech
2.9.1 Business Overview
2.9.2 Anti-Senescence Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Numeric Biotech Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.10 Recursion Pharmaceuticals
2.10.1 Business Overview
2.10.2 Anti-Senescence Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Recursion Pharmaceuticals Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.11 Proteostasis Therapeutics
2.11.1 Business Overview
2.11.2 Anti-Senescence Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Proteostasis Therapeutics Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.12 Senolytic Therapeutics
2.12.1 Business Overview
2.12.2 Anti-Senescence Therapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Senolytic Therapeutics Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.13 Allergan
2.13.1 Business Overview
2.13.2 Anti-Senescence Therapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Allergan Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global Anti-Senescence Therapy Market Competition, by Players
3.1 Global Anti-Senescence Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Anti-Senescence Therapy Players Market Share
3.2.2 Top 10 Anti-Senescence Therapy Players Market Share
3.3 Market Competition Trend
4 Global Anti-Senescence Therapy Market Size by Regions
4.1 Global Anti-Senescence Therapy Revenue and Market Share by Regions
4.2 North America Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
4.5 South America Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
5 North America Anti-Senescence Therapy Revenue by Countries
5.1 North America Anti-Senescence Therapy Revenue by Countries (2014-2019)
5.2 USA Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
6 Europe Anti-Senescence Therapy Revenue by Countries
6.1 Europe Anti-Senescence Therapy Revenue by Countries (2014-2019)
6.2 Germany Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
6.3 UK Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
6.4 France Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Anti-Senescence Therapy Revenue by Countries
7.1 Asia-Pacific Anti-Senescence Therapy Revenue by Countries (2014-2019)
7.2 China Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
7.5 India Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
8 South America Anti-Senescence Therapy Revenue by Countries
8.1 South America Anti-Senescence Therapy Revenue by Countries (2014-2019)
8.2 Brazil Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Anti-Senescence Therapy by Countries
9.1 Middle East and Africa Anti-Senescence Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
10 Global Anti-Senescence Therapy Market Segment by Type
10.1 Global Anti-Senescence Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global Anti-Senescence Therapy Market Forecast by Type (2019-2024)
10.3 Gene Therapy Revenue Growth Rate (2014-2024)
10.4 Immunotherapy Revenue Growth Rate (2014-2024)
10.5 Others Revenue Growth Rate (2014-2024)
11 Global Anti-Senescence Therapy Market Segment by Application
11.1 Global Anti-Senescence Therapy Revenue Market Share by Application (2014-2019)
11.2 Anti-Senescence Therapy Market Forecast by Application (2019-2024)
11.3 Cardiovascular Diseases Revenue Growth (2014-2019)
11.4 Neural Degenerative Diseases Revenue Growth (2014-2019)
11.5 Ophthalmology Disorders Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global Anti-Senescence Therapy Market Size Forecast (2019-2024)
12.1 Global Anti-Senescence Therapy Market Size Forecast (2019-2024)
12.2 Global Anti-Senescence Therapy Market Forecast by Regions (2019-2024)
12.3 North America Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
12.4 Europe Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
12.6 South America Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Anti-Senescence Therapy Picture
Table Product Specifications of Anti-Senescence Therapy
Table Global Anti-Senescence Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Anti-Senescence Therapy Revenue Market Share by Types in 2018
Figure Gene Therapy Picture
Figure Immunotherapy Picture
Figure Others Picture
Table Global Anti-Senescence Therapy Revenue (Million USD) by Application (2014-2024)
Figure Anti-Senescence Therapy Revenue Market Share by Applications in 2018
Figure Cardiovascular Diseases Picture
Figure Neural Degenerative Diseases Picture
Figure Ophthalmology Disorders Picture
Figure Others Picture
Table Global Market Anti-Senescence Therapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Anti-Senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Anti-Senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Anti-Senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Anti-Senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Anti-Senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Anti-Senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Table Unity Biotechnology Basic Information, Manufacturing Base and Competitors
Table Unity Biotechnology Anti-Senescence Therapy Type and Applications
Table Unity Biotechnology Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table OisinBiotechnologies Basic Information, Manufacturing Base and Competitors
Table OisinBiotechnologies Anti-Senescence Therapy Type and Applications
Table OisinBiotechnologies Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table AgeX Therapeutics，Inc Basic Information, Manufacturing Base and Competitors
Table AgeX Therapeutics，Inc Anti-Senescence Therapy Type and Applications
Table AgeX Therapeutics，Inc Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Siwa Therapeutics Basic Information, Manufacturing Base and Competitors
Table Siwa Therapeutics Anti-Senescence Therapy Type and Applications
Table Siwa Therapeutics Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Cleara Biotech Basic Information, Manufacturing Base and Competitors
Table Cleara Biotech Anti-Senescence Therapy Type and Applications
Table Cleara Biotech Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Calico LLC Basic Information, Manufacturing Base and Competitors
Table Calico LLC Anti-Senescence Therapy Type and Applications
Table Calico LLC Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Sierra Sciences Basic Information, Manufacturing Base and Competitors
Table Sierra Sciences Anti-Senescence Therapy Type and Applications
Table Sierra Sciences Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Human Longevity, Inc. (HLI) Basic Information, Manufacturing Base and Competitors
Table Human Longevity, Inc. (HLI) Anti-Senescence Therapy Type and Applications
Table Human Longevity, Inc. (HLI) Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Numeric Biotech Basic Information, Manufacturing Base and Competitors
Table Numeric Biotech Anti-Senescence Therapy Type and Applications
Table Numeric Biotech Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Recursion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Recursion Pharmaceuticals Anti-Senescence Therapy Type and Applications
Table Recursion Pharmaceuticals Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Proteostasis Therapeutics Basic Information, Manufacturing Base and Competitors
Table Proteostasis Therapeutics Anti-Senescence Therapy Type and Applications
Table Proteostasis Therapeutics Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Senolytic Therapeutics Basic Information, Manufacturing Base and Competitors
Table Senolytic Therapeutics Anti-Senescence Therapy Type and Applications
Table Senolytic Therapeutics Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Anti-Senescence Therapy Type and Applications
Table Allergan Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global Anti-Senescence Therapy Revenue (Million USD) by Players (2014-2019)
Table Global Anti-Senescence Therapy Revenue Share by Players (2014-2019)
Figure Global Anti-Senescence Therapy Revenue Share by Players in 2017
Figure Global Anti-Senescence Therapy Revenue Share by Players in 2018
Figure Global Top 5 Players Anti-Senescence Therapy Revenue Market Share in 2018
Figure Global Top 10 Players Anti-Senescence Therapy Revenue Market Share in 2018
Figure Global Anti-Senescence Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Anti-Senescence Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global Anti-Senescence Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Anti-Senescence Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Anti-Senescence Therapy Revenue Market Share by Regions in 2018
Figure North America Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Europe Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure South America Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Table North America Anti-Senescence Therapy Revenue by Countries (2014-2019)
Table North America Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Anti-Senescence Therapy Revenue Market Share by Countries in 2018
Figure USA Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Canada Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Mexico Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Table Europe Anti-Senescence Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure Europe Anti-Senescence Therapy Revenue Market Share by Countries in 2018
Figure Germany Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure UK Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure France Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Russia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Italy Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Anti-Senescence Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Anti-Senescence Therapy Revenue Market Share by Countries in 2018
Figure China Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Japan Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Korea Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure India Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Table South America Anti-Senescence Therapy Revenue by Countries (2014-2019)
Table South America Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Anti-Senescence Therapy Revenue Market Share by Countries in 2018
Figure Brazil Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Argentina Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Colombia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Anti-Senescence Therapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anti-Senescence Therapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure UAE Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Egypt Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure South Africa Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Table Global Anti-Senescence Therapy Revenue (Million USD) by Type (2014-2019)
Table Global Anti-Senescence Therapy Revenue Share by Type (2014-2019)
Figure Global Anti-Senescence Therapy Revenue Share by Type (2014-2019)
Figure Global Anti-Senescence Therapy Revenue Share by Type in 2018
Table Global Anti-Senescence Therapy Revenue Forecast by Type (2019-2024)
Figure Global Anti-Senescence Therapy Market Share Forecast by Type (2019-2024)
Figure Global Gene Therapy Revenue Growth Rate (2014-2019)
Figure Global Immunotherapy Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Anti-Senescence Therapy Revenue by Application (2014-2019)
Table Global Anti-Senescence Therapy Revenue Share by Application (2014-2019)
Figure Global Anti-Senescence Therapy Revenue Share by Application (2014-2019)
Figure Global Anti-Senescence Therapy Revenue Share by Application in 2018
Table Global Anti-Senescence Therapy Revenue Forecast by Application (2019-2024)
Figure Global Anti-Senescence Therapy Market Share Forecast by Application (2019-2024)
Figure Global Cardiovascular Diseases Revenue Growth Rate (2014-2019)
Figure Global Neural Degenerative Diseases Revenue Growth Rate (2014-2019)
Figure Global Ophthalmology Disorders Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Anti-Senescence Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Anti-Senescence Therapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Anti-Senescence Therapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
Figure Europe Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
Figure South America Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
長寿及び抗老化療法の世界市場 2019年版：種類別（溶血性薬物療法、遺伝子療法、免疫療法、その他の幹細胞療法）、用途別（病院、医療機関、医薬品＆デバイス販売） Scope of the Report: The global Longevity and Anti-senescence Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especial…- 世界の遺伝子治療市場予測（～2024年） Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, t…
- 時差ぼけ治療APPの世界市場 2019年版：種類別（Android、iOS）、用途別（ビジネス旅行者、キャビンクルー、アスリート、季節旅行者、その他） Scope of the Report: The global Jet Lag Therapy APP market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also …
- 転移性悪性黒色腫療法の世界市場 2019年版：種類別（免疫療法、標的療法、その他）、用途別（病院、医学研究機関、その他） Scope of the Report: The global Metastatic Malignant Melanoma Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especial…
- 世界の腫瘍学における遺伝子治療市場予測（～2024年）：企業別、地域別、種類・用途別 Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient. Scope of the Report: The global Gene Therapy in Oncology market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a…